September 25, 2007 – VisualDxHealth, an online consumer health resource developed by the doctors and health care professionals at Logical Images, announced today the release of a series of interactive Web widgets.

The widgets are the first of their kind and are designed to help consumers recognize early signs of skin cancer. The “ABCs of Melanoma Identification” and “Skin Cancer Self Exam” widgets are now available online and provide a way for individuals to add trusted health information directly to their Web site, blog,or desktop.

September 25, 2007 - As funding for behavioral health services remains inadequate, the American Hospital Association (AHA) has released a report to assist hospitals facing a growing demand for such services.
The report, developed by the 18-member AHA Behavioral Health Task Force, offers recommendations to improve behavioral health services.

September 25, 2007 – The world’s first patient to undergo brain surgery while conscious and speaking to his doctors during the procedure said it was odd to hear the doctors talking to each other as he lay on the operating table with a half-an-inch hole in his head.
John James, 78, spoke about his experiences at a press conference Sept. 24, at the Canberra Hospital in Australia. He said he was confident in his doctors and did not worry during the procedure.

September 25, 2007 - Quantum Medical Imaging was recently awarded a 3-year contract with Premier, a Group Purchasing Organization (GPO), teaming up to offer digital and cassette-based radiography systems.

Quantum’s Q-Rad Radiographic Systems are an advanced solution offering a variety of optional features and additions to the base unit that work within the constraints of its environment.

For more information: www.quantummedical.net and www.premierinc.com

September 25, 2007 - The Medipattern Corp. recently announced seven new B-CAD products: six versions of B-CAD for breast ultrasound imaging and one version for breast MRI (magnetic resonance imaging), which will be shown at RSNA 2007, as well as works-in-progress for CAD on whole-breast ultrasound.

September 25, 2007 - Findings in a new study, published in the February 2007 issue of Lasers in Surgery and Medicine, suggest a new way to help protect the skin during radiation therapy.

Conducted by Maitland DeLand M.D., oncologist and president of OncoLogics Inc., the study illustrates how GentleWaves LED Photomodulation, manufactured by Light BioScience, significantly reduced the incidence and degree of radiation-induced dermatitis.

September 25, 2007 - MEDRAD Inc. has partnered with the National Prostate Cancer Coalition (NPCC) to provide information about prostate magnetic resonance (MR) imaging to the men who participate in NPCC’s free mobile screening program.

September 25, 2007 - According to a study focusing on non-mass enhancing breast lesions, appearing in the October issue of the journal Radiology, proton magnetic resonance spectroscopy (1H MRS) used in conjunction with magnetic resonance imaging (MRI) can aid radiologists in diagnosing breast cancer while reducing the number of false-positive results and invasive biopsies

“All of the cancers present in this study were identified with MR spectroscopy,” said the study’s lead author, Lia Bartella, M.D., director of breast imaging at Eastside Diagnostic Imaging in New York City.

September 25, 2007 - According to a study published in the October issue of Radiology, researchers using functional magnetic resonance imaging (fMRI) have found a new marker that may aid in early diagnosis of Alzheimer’s disease.

“The findings of this study implicate a potential functional, rather than structural, brain marker—separate from atrophy—that may help enhance diagnosis and treatment monitoring of Alzheimer’s patients,” said the study’s lead author, Jeffrey R. Petrella, M.D., associate professor of radiology at Duke University Medical Center in Durham, N.C.

September 24, 2007 — Integra LifeSciences Holdings Corp. recently announced the release of the OCS2 Ojemann Cortical Stimulator at this week's annual meeting of the Congress of Neurological Surgeons in San Diego, CA.

The OCS2 Ojemann Cortical Stimulator has an FDA clearance in the United States and a CE Mark Certification in the European Union.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now